Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features
Paul A James, Sarah Sawyer, Samantha Boyle, Mary-Anne Young, Serguei Kovalenko, Rebecca Doherty, Joanne McKinley, Kathryn Alsop, Victoria Beshay, Marion Harris, Stephen Fox, Geoffrey J Lindeman, Gillian Mitchell
Familial Cancer | SPRINGER | Published : 2015
Awarded by Victorian Cancer Agency
The authors gratefully acknowledge the assistance of Rebecca Driessen and Kylie Shackleton for the Victorian Familial Cancer Clinical Trials Group, along with Megan Rehfisch, Steven Macaskill, Ayiguli Ha, Jamie Thiessen, Elvina Johnston, Chris Michael-Lovatt and the Genetic Counsellors of the Victorian FCCs. This study was supported by funding from the Department of Health, Victoria (Australia). The Victorian Familial Cancer Clinical Trials Group was supported by the Victorian Cancer Agency (EOI09-50). GJL was supported by a NHMRC research fellowship, the Victorian Breast Cancer Research Consortium and State Government Operational Infrastructure Support.